Peijia Medical Limited (SEHK: 9996)
Health Care · Health Care Equipment & Supplies · CN
HK$4.63
+1.20% today · -26.9% 1Y
Peijia Medical Limited (SEHK: 9996) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $396.84M and employs 1,033 people.
Over the last twelve months the share price has lost 26.9%, trading between 3.73 and 7.37.
Tweenvest scores Peijia Medical Limited across four factors: quality 59/100, value 67/100, growth 100/100. Its strongest factor is growth.
9996 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $396.84M
- Revenue (TTM)
- $115.42M
- P/E
- —
- EPS
- -0.21
- Dividend yield
- —
- Beta (5Y)
- 0.61
- 52-week high
- HK$7.37
- 52-week low
- HK$3.73
- Avg volume (3M)
- —
- Shares outstanding
- 672.63M
- Employees
- 1,033
- Next earnings
- —
About Peijia Medical Limited
Peijia Medical Limited specializes in the innovation and development of advanced medical devices for transcatheter valve therapies and neurointerventional procedures. Their extensive portfolio of transcatheter valve solutions includes numerous TAVR (transcatheter aortic valve replacement) systems, such as TaurusOne, the retrievable TaurusElite, TaurusNXT (a non-glutaraldehyde dry-tissue system), TaurusApex (featuring polymer leaflets), and Trilogy. For mitral valve interventions, they offer the HighLife transseptal replacement system, SpyderOne (a transapical TMVR system), Sutra for coaptation augmentation, and the GeminiOne edge-to-edge repair system. They also provide the MonarQ and Peijia systems for transcatheter tricuspid valve replacement. Complementary devices supporting these procedures include the TaurusAtlas transfemoral balloon catheter, TaurusExplora pre-shaped guidewire, and introducer sheaths. In the neurointerventional field, Peijia Medical develops devices like the Jasper and Presgo detachable coils (including the Jasper SS variant), various intracranial adjunctive stents such as NeuroStellar, and the SacSpeed balloon dilatation catheter. Additional offerings comprise the Tethys AS aspiration catheter, Syphonet stent retriever, Neway balloon microcatheter, Fluxcap balloon guiding catheter, Presgo microcatheters and micro guidewires, Heralder guiding and distal access catheters, the Tethys intermediate catheter, and the Jasper power supply. Furthermore, the company engages in trading activities. Peijia Medical Limited was founded in 2012 and is headquartered in Suzhou, People's Republic of China.
- ISIN
- KYG6981F1090
- Founded
- 2012
- Listed since
- May 15, 2020
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Nanjing Medlander Medical Technology Co.,Ltd.SHSE: 688273 | $406.67M | CN¥27.85 | -5.59% |
| Ningbo Tianyi Medical Appliance Co., Ltd.SZSE: 301097 | $404.68M | CN¥34.20 | -1.44% |
| Shenzhen Bioeasy Biotechnology Co., Ltd.SZSE: 300942 | $400.96M | CN¥6.63 | -0.30% |
| OrbusNeich Medical Group Holdings LimitedSEHK: 6929 | $400.74M | HK$3.82 | +0.66% |
| Chongqing Xishan Science & Technology Co., Ltd.SHSE: 688576 | $396.68M | CN¥39.55 | -0.75% |
| Chemclin Diagnostics Co., Ltd.SHSE: 688468 | $394.12M | CN¥6.69 | +2.45% |
| Carlsmed, Inc.NasdaqGS: CARL | $393.71M | $14.70 | +1.94% |
| CellaVision AB (publ)OM: CEVI | $385.95M | Skr163.20 | +0.87% |
Figures last refreshed Oct 11, 2026.